Alleviant Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Alleviant Medical, Inc. - overview
Established
2017
Location
Austin, TX, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2017 and based in Texas, US, Alleviant Medical, Inc. is a manufacturer of medical devices that develops and produces implant-free interatrial shunt devices for the treatment of chronic heart failure. In January 2023, Alleviant Medical raised USD 75 million in venture funding co-led by new investors S3 Ventures and RiverVest Ventures, with participation from other new investors Gilmartin Capital, Longview Ventures, ShangBay Capital, Texas Medical Center Ventures, and Vensana Capital. As of January 2023, the firm is being led by its CEO, Adam Berman.
The firm develops a medical device called Alleviant (ALV1) that operates as a durable interatrial shunt without requiring a permanent implant used for the treatment of heart failures with preserved ejection fraction (HFpEF).
Current Investors
RiverVest Ventures Partners, S3 Ventures, Texas Medical Center Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Cardiology, Monitoring Equipment
Website
www.alleviantmedical.com
Verticals
HealthTech, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.